Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates pathological retinal angiogenesis by suppressing vascular endothelial growth factor-induced Arf6 activation

Seo, S; Kim, MK; Kim, RI; Yeo, Y; Kim, KL; Suh, W

Kim, KL; Suh, W (corresponding author), Chung Ang Univ, Coll Pharm, Dept Globa & Innovat Drug, Seoul 06974, South Korea.

EXPERIMENTAL AND MOLECULAR MEDICINE, 2020; 52 (10): 1744